SUMMARY A group of 16 patients with a disproportionate polyclonal increase in their serum IgGl, resulting in raised concentrations of total IgG immunoglobulin, has been discovered. The other IgG subclasses in these patients are either normal or slightly reduced, resulting in an IgGl:IgG2 ratio of at least 10:1. Most cases are marked by the presence of anti-extractable nuclear antigen (anti-ENA) antibodies and high titres of rheumatoid factor and antinuclear antibody. All but one patient has a connective tissue disease, nearly twice the prevalence found in similarly hypergammaglobulinaemic patients without this IgG subclass imbalance. Among patients with systemic lupus erythematosus (SLE), those with the IgGl disorder have a higher prevalence of high titre rheumatoid factor and antinuclear antibody, but a lower prevalence of anti-double-stranded DNA (anti-dsDNA) antibodies above 30 U/ml. It is suggested that this immunoglobulin abnormality may reflect a unique immunoregulatory dysfunction in these patients.
Immunoglobulin abnormalities have been reported in association with connective tissue diseases (CTD). Systemic lupus erythematosus (SLE), for example, is characterised by hypergammaglobulinaemia, increased spontaneously activated B cells, and increased immunoglobulin-secreting cells in both patients and mouse models of the disease. '-5 CTD are also characterised by autoantibody formation. These antibodies, such as antigammaglobulin, antinuclear, anti-RNP, anti-Sm, anti-La, and anti-DNA antibodies, are predominantly of the IgGl and IgG3 isotypes. 6 Measurement of anti-double-stranded DNA antibodies Anti-double-stranded DNA (anti-dsDNA) antibodies were measured using a modification of the ELISA method described elsewhere.'5 Antibody levels were estimated relative to a positive reference serum and expressed in arbitrary units/ml, taking levels of greater than 30 units/ml as being suggestive of SLE in this laboratory. 17 eight of these were classified as suffering from SLE and two from rheumatoid arthritis (RA). Two (Table 4) . High levels of anti-dsDNA were more prevalent in the hypergammaglobulinaemic SLE comparison group. With CTD* SLE (9) SLE (9) RA (2) RA (9) MCTD (2) MCTD (1) SS (2 Table 2 .
Discussion
Our computerised filing system18 has enabled us to identify an unusual subset of patients who have a distinctive immunoglobulin imbalance. One patient with a very high concentration of polyclonal IgGl initially alerted us to the phenomenon. When the abnormality was defined as a raised concentration of IgGl, with an IgGl:IgG2 ratio of 10:1, a search of our data files disclosed 15 more patients with this pattern of results. These patients not only had the IgG subclass imbalance but also a distinct autoantibody pattern with high titres of ANAs and rheumatoid factor and the presence of anti-ENA antibodies in most cases. The prevalence of CTD was about twice that of other patients with a similarly raised immunoglobulin G concentration without the subclass imbalance. Studies are underway to ascertain the overall prevalence of this subclass imbalance in CTD. In one patient presenting with urticaria and angiodema the immunological abnormalities were detected some 18 months before SLE became clinically apparent. We have heard of two nephritic patients who had high concentration of IgGl before the development of Sjogren's syndrome. Thus IgG subclass imbalance, though spanning the usual clinical subdivisions, may be an early indication of CTD in evolution.
The precise cause of B cell overactivity in CTD is unknown but among the possibilities are genetic factors, unidentified polyclonal B cell activators, and defective immunoregulation.' Most studies of SLE in both humans and mice have found defective suppressor function,'B23 but in the MRL mouse model there is excessive helper cell activity.5
Increased lymphocyte transformation and lymphokine production in cartilage-type proteoglycan and collagen derived antigens have been described in a range of connective tissue disorders,24 and animal studies have shown that effector and helper T cell functions may be mediated by the same cell. 25 
